Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (16377)	3/4/1998 8:04:00 AM
From: Alper H.YUKSEL	Read Replies (3) \| Respond to of 32384

Henry, Having tested the magical 15 1/4 yesterday, though on somewhat low volume, today could be the judgement day, that P^2 was talking about. The positive fundamentals are certainly there, and everyday brings us closer to the announcements. I hate myself for not having shorted AMLN last week. I was following it for a short candidate, since it was testing 5 for a while. Yesterday has proven to me once again that biotechs are really not for the faint-hearted. Before stumbling on to the LGND thread last year, I had pondered buying IPIC as well. Look where the stock stands now after the Redux fiasco. Initially, I had not liked the fact that LGND has many partnerships with the pharma big boys, as I viewed it as a lack of concentration on fewer and more important areas, as well as a sign of LGND planning to remain solely an R&D powerhouse. After I've witnessed the slaughtering of a few one-trick ponys, I started to interpret the above as a strength rather than a weakness. Regards Alper